Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY‐1, SIMPLIFY‐2, and MOMENTUM Trials

Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY‐1, SIMPLIFY‐2, and MOMENTUM Trials

ABSTRACT Introduction Myelofibrosis is characterized by debilitating constitutional symptoms and anemia, which negatively impact survival and quality of life. Red blood cell transfusions form the basis of anemia management in myelofibrosis but dependence on transfusions is further associated with po...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruben A. Mesa, Moshe Talpaz, Flora Mazerolle, Boris Gorsh, Manal M'Hari, Antoine Regnault, Catherine Ellis, Zhaohui Wang, Molly Purser, Tom Liu, Bryan Strouse, Dwaipayan Patnaik
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:eJHaem
Subjects:
JAK inhibitor
momelotinib
myelofibrosis
quality of life
survival
transfusions
Online Access:https://doi.org/10.1002/jha2.70075
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items